Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease
Among genetic abnormalities identified in Parkinson's disease (PD), mutations of the leucine-rich repeat kinase2 (LRRK2) gene, such as the G2019S missense mutation linked to enhanced kinase activity, are the most common. While the complex role of LRRK2 has not been fully elucidated, evidence th...
Main Authors: | Alessandro Tozzi, Valentina Durante, Guendalina Bastioli, Petra Mazzocchetti, Salvatore Novello, Alessandro Mechelli, Michele Morari, Cinzia Costa, Andrea Mancini, Massimiliano Di Filippo, Paolo Calabresi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-10-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996118301852 |
Similar Items
-
Autophagy and LRRK2 in the Aging Brain
by: Federica Albanese, et al.
Published: (2019-12-01) -
From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2
by: Andrea Mancini, et al.
Published: (2020-07-01) -
Pathway-specific dysregulation of striatal excitatory synapses by LRRK2 mutations
by: Chuyu Chen, et al.
Published: (2020-10-01) -
Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic Mice
by: Joanna A. Korecka, et al.
Published: (2020-09-01) -
Pharmacodynamic Biomarkers for Emerging LRRK2 Therapeutics
by: Kaela Kelly, et al.
Published: (2020-08-01)